Ipsen SA (IPSEF) Full Year 2024 Earnings Call Highlights: Strong Sales Growth and Strategic ... [Yahoo! Finance]
IPSEN SA S/ADR (IPSEY)
NASDAQ:AMEX Investor Relations:
ipsen.com/investors
Company Research
Source: Yahoo! Finance
4 min read In This Article IPSEY Total Sales Growth: 9.9% at constant exchange rates, exceeding EUR3.4 billion. Core Operating Margin: Core Operating Income: EUR1.1 billion, a growth of 10.8%. Free Cash Flow: EUR774 million, an increase of 8.9%. Revenue from Ex-Somatuline Portfolio: Grew by 12.2%. Cabometyx Sales: Increased by 13.3% for the full year. ONIVYDE Sales: Grew 23.7% for the full year. Fidrisertib Sales: Rose by 24%. Dysport Sales Growth: 9.2% for the full year. Bylvay Sales: EUR136 million. IQIRVO Sales: EUR22 million. R&D Costs: Increased by 10.9%, exceeding 20% of sales. SG&A Costs: Increased by 3.3%, with a ratio to sales at 34.4%. Net Cash Position: EUR160 million at the end of December. Dividend Increase: From EU
Read more
Impact Snapshot
Event Time:
IPSEY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPSEY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPSEY alerts
High impacting IPSEN SA S/ADR news events
Weekly update
A roundup of the hottest topics
IPSEY
News
- Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidanceGlobeNewswire
- Ipsen S.A. (OTCMKTS: IPSEY) had its "buy" rating re-affirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- Ipsen announces issuance of €500 million inaugural Rated Public BondGlobeNewswire
- Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of NeurotoxinsGlobeNewswire
- Marengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with IpsenPR Newswire